Multiple System Atrophy: The chronic, progressive, neurodegenerative synucleinopathic disease Hardcover – May 17, 2023

★★★★★ 4.6 99 reviews

US$19.00
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by arkemetal.com.ar
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$19.00
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 6
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by arkemetal.com.ar
Free 30-day returns Details

Product details

Management number 222225211 Release Date 2026/05/04 List Price US$19.00 Model Number 222225211
Category

Multiple system atrophy is a rare condition of the nervous system that causes gradual damage to nerve cells in the brain and spinal cord and progressive loss of associated functions. It is a member of a class of neurodegenerative diseases known as synucleinopathies that have in common an abnormal accumulation of the alpha-synuclein protein in various parts of the brain. The hallmark of the disease is the widespread inclusions of misfolded alpha-synuclein protein - the same protein involved in Parkinson's disease. This book will describe the clinical presentations of the disease, types and variants, diagnostic tests used, drugs employed, and therapies administered. The tests can only help determine whether the diagnosis is 'probable' or 'possible' since no laboratory or imaging studies are able to definitively confirm the diagnosis and there are no useful biomarkers. No test can provide a definitive diagnosis, which remains challenging and difficult in part because of many confounding diseases. Because of this difficulty, some people are actually never properly diagnosed or may not ever be diagnosed. The portfolio of the majority of the developed therapeutic approaches is presented. It includes the panoply of drugs, clinical trials, and the newer modalities of immunotherapy, gene therapy, and mesenchymal stem cell therapy. Unfortunately, there is no cure as the alpha-synuclein processes are only symptoms, not the root cause(s), of the disease so the proximal trigger remains unknown. Regardless, while prognosis and future outlook are poor, there is valuable support from numerous advocating and supporting organizations. There is also hope for the future as research has made excellent progress, especially in the development of new treatment options. A shift in thinking about the disease is still needed with greater consideration given to the potential underlying degenerative etiology that will eventually unravel the mystery and provide a cure. Read more

ISBN10 0228894433
ISBN13 978-0228894438
Language English
Publisher Tellwell Talent
Dimensions 8.5 x 0.94 x 11 inches
Item Weight 2.72 pounds
Print length 302 pages
Publication date May 17, 2023

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.6 out of 5
★★★★★
99 ratings | 41 reviews
How item rating is calculated
View all reviews
5 stars
84% (83)
4 stars
3% (3)
3 stars
2% (2)
2 stars
1% (1)
1 star
10% (10)
Sort by

There are currently no written reviews for this product.